Skip to content

KUREKraneShares MSCI All China Health Care Index ETF

Grow my money8y track recordRanked #1,386 of 2,960 in this goal

Seeks to provide investment results that track the price and yield performance of the MSCI China All Shares Health Care 10/40 Index.

By KraneShares · Launched 2018

Annual Cost

0.65%

#3,297 of 5,562 · average

Fund Size

$73M

#3,217 of 5,562 · mid-size

Return (1Y)Goal

-9.3%

Track Record

8 years

#1,705 of 5,562 · established

Performance

Total-return NAV · USD
Growth of $10,000
$9,121-8.8%

Total-return NAV, USD. Net of fund fees, before tax.

Classification

How Beacon categorizes this fund

Asset class

Equity

Cap

Multi cap

Strategy

Index tracking

Index tracked

MSCI China All Shares Health Care 10/40 Index

What it actually holds

By weight

Concentration

Top 10 holdings = 55.3% of fundmoderately concentrated

BeOne Medicines AG
8.4%
Jiangsu Hengrui Pharmaceuticals Co.,Ltd
8.3%
INNOVENT BIOLOGICS, INC.
7.2%
WUXI BIOLOGICS (CAYMAN) INC.
7.0%
Akeso Inc
4.7%
Shenzhen Mindray Bio-Medical Electronics Co Ltd
4.5%
CSPC PHARMACEUTICAL GROUP LIMITED
4.4%
SINO BIOPHARMACEUTICAL LIMITED
4.1%
HANSOH PHARMACEUTICAL GROUP COMPANY LIMITED
3.5%
WuXi AppTec Co., Ltd.
3.2%

Asset allocation

Stocks
99.1%
Cash
0.9%

By sector

Healthcare
99.3%
Consumer Defensive
0.7%

Risk profile

Last 12 months · Sharpe & Sortino need 3+ years
Volatility (1Y)
26.2%High

Year-on-year price swings

Max drawdown
-68.5%Severe

Worst peak-to-trough loss

Sharpe (3Y)
-0.19Below average
Sortino (3Y)
-0.26Moderate downside risk

Where to buy

Listing

Exchange
NYSE Arca

Full fund details

Objective
Seeks to provide investment results that track the price and yield performance of the MSCI China All Shares Health Care 10/40 Index.
Strategy
Invests primarily in securities of the MSCI China All Shares Health Care 10/40 Index, including A-Shares, B-Shares, and H-Shares. May use representative sampling to track the index.
Inception date
January 31, 2018
Fund family
KraneShares

What's next?

You've reviewed KURE. Save it to your watchlist to track it alongside the other funds you're weighing.

Data updated on 2026-06-19